Skip to content

A randomized controlled study of improved pelvic sacral moxibustion in the prevention and treatment of primary dysmenorrhea with cold coagulation and blood stasis

A randomized controlled study of improved pelvic sacral moxibustion in the prevention and treatment of primary dysmenorrhea with cold coagulation and blood stasis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006074
Enrollment
Unknown
Registered
2022-06-06
Start date
2022-06-16
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary dysmenorrhea with cold coagulation and blood stasis

Interventions

improved pelvic sacral moxibustion group:improved pelvic sacral moxibustion
traditional ginger pelvic sacral moxibustion group:traditional ginger pelvic sacral moxibustion

Sponsors

The Third Affiliated Hospital of Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: ? Women aged between 18 and 50; ? Regular menstrual cycle (21±7 days); ? Color ultrasound and gynecological examination showed no organic disease; ? Dysmenorrhea VAS (visual analog score) >40 at the time of inclusion ? In the menstrual cycle prior to this treatment, no other treatment was received, and no analgesics, sedatives or hormone drugs were taken; ? Nearly half a year without pregnancy plan; ? The patients voluntarily participate and sign the informed consent.

Exclusion criteria

Exclusion criteria: ? Breast-feeding women; ? Those who suffer from other serious systemic diseases, such as cardiovascular diseases and malignant tumors, and those who are considered unsuitable for the study by the researcher; ? Those who are currently undergoing other treatments (drug or non-drug), which may affect the measurement of effect indicators in this study; ? Do not cooperate with treatment plan arrangement; ? Fever or other factors resulting in abnormal body temperature; ? Superficial sensory disorders; ? People who are allergic to ginger or alcohol.

Design outcomes

Primary

MeasureTime frame
Severity of dysmenorrhea;

Secondary

MeasureTime frame
infrared thermography;TCM symptoms and signs;Menstruation situation;Hemodynamic examination of endometrium and uterine artery;

Countries

China

Contacts

Public ContactChen Lifang
clang@163.com13957157278

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026